Literature DB >> 31025872

Wnt/β-Catenin Signaling Pathway-Related Proteins (DKK-3, β-Catenin, and c-MYC) Are Involved in Prognosis of Nasopharyngeal Carcinoma.

Qiran Pang1, Wenting Hu1, Xinglin Zhang2, Mingjie Pang1.   

Abstract

The Wnt/β-catenin signaling pathway is one of the highly conserved signaling pathway widely reported to play essential roles in the development of various tumors and human cancers, thus serving as a potential target for anticancer therapy. However, the specific effects of the related proteins in the Wnt/β-catenin signaling pathway in nasopharyngeal carcinoma (NPC) still remain elusive. Thus, this study was performed to uncover the correlation between the Wnt/β-catenin signaling pathway-related proteins and the clinical characteristics and prognosis of NPC. NPC tissues were revealed to present high expression of β-catenin and v-myc myelocytomatosis viral oncogene homolog (c-MYC) but low expression of Dickkopf-3 (DKK-3). Immunohistochemical staining revealed that DKK-3 was positively linked to but β-catenin and c-MYC were negatively linked to differentiation, tumor-node-metastasis (TNM) stage and lymph node metastasis of patients with NPC. In addition, c-MYC was identified to be positively correlated to DKK-3 in NPC tissues. The positive expression of β-catenin and c-MYC had negative relations with and that of DKK-3 had positive relations with survival rate of patients with NPC, which was analyzed by Kaplan-Meier method. Moreover, it was shown that later TNM stage and positive expression of β-catenin were risk factors for NPC-related death. These findings provide evidence that the proteins related to the Wnt/β-catenin signaling pathway (DKK-3, β-catenin, and c-MYC) participate in the development of NPC and positive expression of DKK-3 and negative expression of β-catenin, and c-MYC can serve as essential prognostic biomarkers, shedding new light on the prognosis and treatment of NPC.

Entities:  

Keywords:  Dickkopf-3; Wnt/β-catenin signaling pathway; nasopharyngeal carcinoma; prognosis; survival rate; v-myc myelocytomatosis viral oncogene homolog

Year:  2019        PMID: 31025872     DOI: 10.1089/cbr.2019.2771

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  6 in total

1.  MicroRNA-384 inhibits nasopharyngeal carcinoma growth and metastasis via binding to Smad5 and suppressing the Wnt/β-catenin axis.

Authors:  Xinyu Zeng; Huiqun Liao; Fusen Wang
Journal:  Cytotechnology       Date:  2021-02-26       Impact factor: 2.058

2.  Cabergoline possesses a beneficial effect on blood-brain barrier (BBB) integrity against lipopolysaccharide (LPS).

Authors:  Lina You; Haidong Jiang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

3.  A Four-Gene Signature Model Improves the Prediction of Distant Metastasis in Patients with Nasopharyngeal Carcinoma: A Retrospective, Three-Center Observational Study.

Authors:  Jinyuan Si; Xiuyong Ding; Zhuoxia Deng; Pu Li; Benjian Zhang; Guiping Lan; Bo Huang; Jinhui Liang; Zhenlin Wang; Yongfeng Si
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

Review 4.  The prognostic significance of β-Catenin expression in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.

Authors:  Liu-Qing Zhou; Jin-Xiong Shen; Tao Zhou; Chun-Li Li; Yao Hu; Hong-Jun Xiao
Journal:  Front Genet       Date:  2022-08-09       Impact factor: 4.772

Review 5.  Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma.

Authors:  Yuanbo Kang; Weihan He; Caiping Ren; Jincheng Qiao; Qiuyong Guo; Jingyu Hu; Hongjuan Xu; Xingjun Jiang; Lei Wang
Journal:  Signal Transduct Target Ther       Date:  2020-10-23

6.  WNT8B as an Independent Prognostic Marker for Nasopharyngeal Carcinoma.

Authors:  Chawalit Ngernsombat; Pongphol Prattapong; Noppadol Larbcharoensub; Krittika Khotthong; Tavan Janvilisri
Journal:  Curr Oncol       Date:  2021-07-08       Impact factor: 3.677

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.